| ONLINE ONLY ARTICLES - LETTER TO EDITOR |
|
| Year : 2022 | Volume
: 6
| Issue : 2 | Page : 155 |
|
|
Cutaneous manifestations of chronic kidney disease - A cross sectional study
Ambresh S Badad, Harshima Gadwal, Ashok S Hogade
Department of Dermatology, Venereology, Leprology, Mahadevappa Rampure Medical College, Kalaburagi, Karnataka, India
Correspondence Address:
Ambresh S Badad
Dr Badad's Skin, Eye and Laser Care Centre, H NO 10-105, 16 A and B, Sharan Nagar, Tank Bund Road, Brahmpur, Kalalburagi - 585 103, Karnataka
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/cdr.cdr_65_21
|
|
|
Background: Systemic disorders often have cutaneous manifestations. Health of the skin usually reflects the overall health of a person. Therefore, early recognition of cutaneous signs and prompt initiation of treatment are essential in reducing morbidity and mortality. Cutaneous changes can be observed in all the stages of renal disease. They can be due to the cause, the disease, or the treatment. Aim: The aim is to study the pattern and proportion of cutaneous manifestation in chronic kidney disease (CKD) patients visiting a tertiary care center. Materials and Methods: This cross-sectional study was carried out at a tertiary care hospital. A total of 80 patients with CKD were included in this study. All patients were clinically examined after written consent. Results: Every patient included in this study had minimum one dermatological manifestation of CKD. The most common cutaneous manifestation was pallor in 80% of patients, followed by xerosis in 60%, pruritus in 50%, pigmentary changes in 40%, and hair changes in 35% of patients. Cutaneous infections were seen in 30%, oral mucosa changes in 20% of patients. Nail changes were observed in 10% of patients, the most common being onychomycosis. Kyrle's disease was seen in 5% of patients. Conclusion: There is a broad range of cutaneous manifestations of CKD. Although often benign, they may negatively impact the quality of life and can be life-threatening. Early detection and treatment are required to decrease the morbidity, mortality, and improve the quality of life of CKD patients.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
